Observational Study Evaluating Long-Term Safety and Effectiveness
of Humira in Patients With Hidradenitis Suppurativa
Recruitment Status: recruiting as of August 2020.
Estimated Completion Date: April 30, 2023
Sponsors and Collaborators: AbbVie
Information provided by (Responsible Party): AbbVie
Brief Summary: The objective of this study is to evaluate the long-term safety and effectiveness of Humira in patients with Hidradenitis Suppurativa (HS) in real-world clinical practice in Japan.
Please link complete details https://clinicaltrials.gov/ct2/show/NCT03894956
Contact: AbbVie GK Clinical Trial Registration Desk, +81-3-4577-1111, email@example.com